ARMP Armata Pharmaceuticals
- 2.670
- +0.090+3.49%
Armata Pharmaceuticals News
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PATTI JOSEPH M
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kramer Robin
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Todd C.
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rychlik Richard
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schlesinger Sarah J.
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Haimovitz Jules
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Odysseas Kostas D
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birx Deborah
Armata Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Innoviva, Inc(85.3%),Innoviva Strategic Opportunities LLC(62.1%)
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schlesinger Sarah J.
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Todd C.
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kramer Robin
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PATTI JOSEPH M
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rychlik Richard
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Haimovitz Jules
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Birx Deborah
Armata Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Odysseas Kostas D
Armata Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Rychlik Richard
Armata Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Birx Deborah
Armata Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Innoviva, Inc.(85.3%),Innoviva Strategic Opportunities LLC(62.1%)
Analysis
Price Target
No Data
